International Clinical Trial: A Phase I Clinical Trial Protocol to Evaluate the Safety and Efficacy of TDI01 Suspension in Subjects with Radiation-Induced Pulmonary Fibrosis

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122091) titled 'A Phase I Clinical Trial Protocol to Evaluate the Safety and Efficacy of TDI01 Suspension in Subjects with Radiation-Induced Pulmonary Fibrosis' on April 9.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: West China Hospital, Sichuan University

Condition: Radiation-Induced Pulmonary Fibrosis

Intervention: TDI01 suspension 200 mg group:TDI01 suspension 200 mg once daily orally

Recruitment Status: Not Recruiting

Phase: 1

Date of First Enrollment: 2026-04-15

Target Sample Size: TDI01 suspension 200 mg group:3;TDI01 suspension 400 mg group:3;

Countries of Recruitment: China...